Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-155169)

Filing Details

Accession Number:: 0001209191-16-155169
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-12-14 16:29:59
Reporting Period:: 2014-04-03

Filing Date:: 2016-12-14
Accepted Time:: 2016-12-14 16:29:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
827871	Eagle Pharmaceuticals Inc.	EGRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1054941	B Steven Ratoff	C/O Eagle Pharmaceuticals, Inc. 50 Tice Blvd., Suite 315 Woodcliff Lake NJ 07677		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-04-03	3,950	$12.79	23,324	No	4	P	Direct
Common Stock	Disposition	2016-12-12	1,300	$75.07	22,024	No	4	S	Direct
Common Stock	Disposition	2016-12-13	8,700	$75.00	13,324	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	S	Direct
No	4	S	Direct